This interaction may manifest through modulation or alteration of neurotransmitter release, receptor activity, or signal transduction pathways, indicating a sophisticated and multifaceted relationship that remains an area of active research
Clean Vial Stoppers and Surfaces: Wipe the rubber stopper of the vial with 70% isopropanol or an alcohol swab before puncturing it with a needle
Suitable for research protocols requiring prolonged stimulation
Approach Loading Per-session dose 500-1,000 mg Schedule 3-5 consecutive days, then weekly/monthly Notes Clinic-supervised only
[DOI] [PubMed] [Google Scholar] 82.Finn R.S., Ryoo B.Y., Merle P., Kudo M., Bouattour M., Lim H.Y., Breder V., Edeline J., Chao Y., Ogasawara S., et al
Further considerations include: Dehydration risk : Combined effects of diarrhoea (from both Crohn's and medication) may increase dehydration risk Medication absorption : While generally minimal, delayed gastric emptying could affect absorption of oral medications with a narrow therapeutic index Monitoring requirements : Regular assessment of disease activity markers, nutritional status, and weight trends is essential Patients should be counselled about these risks and encouraged to report any worsening gastrointestinal symptoms promptly to the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk), as distinguishing between expected side effects and disease progression requires clinical expertise
